High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 795-804

  Härdtner, Carmen ^a   Mörke, Caroline ^a   Walther, Reinhard ^a   Wolke, Carmen ^a   Lendeckel, Uwe ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

cell; Alternative renin angiotensin system; BRIN BD11 cells; High glucose; Renin angiotensin system

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN CONVERTING ENZYME 2; GLUCOSE; GLUTAMYL AMINOPEPTIDASE; INSULIN; INSULIN REGULATED AMINOPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HYPERGLYCEMIA; HYPERTENSION; IMMUNOBLOTTING; INSULIN RELEASE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CELL LINE; CYSTINYL AMINOPEPTIDASE; GLUCOSE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; PEPTIDYL-DIPEPTIDASE A; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84883363059     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1469     Document Type: Article

References (30)

1. Ahmed AM: History of diabetes mellitus. Saudi Med J 23: 373-378, 2002.
2. International Diabetes Federation: The Global Burden. IDR Diabetes Atlas. 5th edition, 2011. http://www.idf.org/diabetesatlas/5e/the-global-burden.
3. Himsworth HP: Diatebetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet: 127-130, 1936.
4. Ahmed AM: History of diabetes mellitus. Saudi Med J 23: 373-378, 2002.
5. International Diabetes Federation: The Global Burden. IDR Diabetes Atlas. 5th edition, 2011. http://www.idf.org/diabetesatlas/5e/the-global-burden.
6. Himsworth HP: Diatebetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet: 127-130, 1936.
7. Tikellis C, Cooper ME and Thomas MC: Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. Int J Biochem Cell Biol 38: 737-751, 2006.
8. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YH, O'Harte FP, Yoon TW, Swanston-Flatt SK and Flatt PR: Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 45: 1132-1140, 1996.
9. Tahmasebi M, Puddefoot JR, Inwang ER and Vinson GP: The tissue renin-angiotensin system in human pancreas. J Endocrinol 161: 317-322, 1999.
10. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC and Cooper ME: Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 53: 989-997, 2004.
11. Lau T, Carlsson PO and Leung PS: Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47: 240-248, 2004.
12. Chu KY, Lau T, Carlsson PO and Leung PS: Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55: 367-374, 2006.
13. Regoli M, Bendayan M, Fonzi L, Sernia C and Bertelli E: Angiotensinogen localization and secretion in the rat pancreas. J Endocrinol 179: 81-89, 2003.
14. Chu KY, Cheng Q, Chen C, Au LS, Seto SW, Tuo Y, Motin L, Kwan YW and Leung PS: Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors. Am J Physiol Cell Physiol 298: C313-C323, 2010.
15. Wong PF, Lee SS and Cheung WT: Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept 117: 195-205, 2004.
16. Bindom SM and Lazartigues E: The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 302: 193-202, 2009.
17. Kobayashi H, Mitsui T, Nomura S, Ohno Y, Kadomatsu K, Muramatsu T, Nagasaka T and Mizutani S: Expression of glucose transporter 4 in the human pancreatic islet of Langerhans. Biochem Biophys Res Commun 314: 1121-1125, 2004.
18. Kobayashi H, Nomura S, Mitsui T, Ito T, Kuno N, Ohno Y, Kadomatsu K, Muramatsu T, Nagasaka T and Mizutani S: Tissue distribution of placental leucine aminopeptidase/oxytocinase during mouse pregnancy. J Histochem Cytochem 52: 113-121, 2004.
19. Lupi R, Del Guerra S, Bugliani M, Boggi U, Mosca F, Torri S, Del Prato S and Marchetti P: The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 154: 355-361, 2006.
20. Leung KK and Leung PS: Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. JOP 9: 290-299, 2008.
21. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, Kim MJ, Jeong IK and Yoon KH: High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 98: 343-355, 2006.
22. Muangman P, Tamura RN and Gibran NS: Antioxidants inhibit fatty acid and glucose-mediated induction of neutral endopeptidase gene expression in human microvascular endothelial cells. J Am Coll Surg 200: 208-215, 2005.
23. Muangman P, Spenny ML, Tamura RN and Gibran NS: Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells. Shock 19: 508-512, 2003.
24. Coelho MS, Lopes KL, Freitas Rde A, de Oliveira-Sales EB, Bergasmaschi CT, Campos RR, Casarini DE, Carmona AK, Araújo Mda S, Heimann JC and Dolnikoff MS: High sucrose intake in rats is associated with increased ACE2 and angiotensin?(1-7) levels in the adipose tissue. Regul Pept 162: 61-67, 2010.
25. Mohammed AM, Syeda K, Hadden T and Kowluru A: Upregulation of phagocyte-like NADPH oxidase by cytokines in pancreatic beta-cells: attenuation of oxidative and nitrosative stress by 2-bromopalmitate. Biochem Pharmacol 85: 109-114, 2013.
26. Syed I, Kyathanahalli CN, Jayaram B, Govind S, Rhodes CJ, Kowluru RA and Kowluru A: Increased phagocyte-like NADPH oxidase and ROS generation in type 2 diabetic ZDF rat and human islets: role of Rac1-JNK1/2 signaling pathway in mitochondrial dysregulation in the diabetic islet. Diabetes 60: 2843-2852, 2011.
27. Michalska M, Wolf G, Walther R and Newsholme P: Effects of pharmacological inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2-induced mouse islet or clonal pancreatic? cell dysfunction. Biosci Rep 30: 445-453, 2010.
28. Abdel-Rahman EM, Abadir PM and Siragy HM: Regulation of renal 12(S)?hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors. Am J Physiol Regul Integr Comp Physiol 295: R1473-R1478, 2008.
29. Carlsson PO, Berne C and Jansson L: Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41: 127-133, 1998.
30. Giani JF, Gironacci MM, Muñoz MC, Peña C, Turyn D and Dominici FP: Angiotensin?(1-7) stimulates the phosphorylation of JAK2, IRS?1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol 293: H1154-1163, 2007.